• Leahy, making sure that the government does not have to disclose any information under the Freedom of Information Act relating to drug inspections from a foreign government agency;
• Sen. Rob PortmanRob PortmanOvernight Finance: Trump threatens NAFTA withdrawal | Senate poised for crucial Puerto Rico vote | Ryan calls for UK trade deal | Senate Dems block Zika funding deal Overnight Energy: Volkswagen reaches .7B settlement over emissions Senators rally for coal miner pension fix MORE (R-Ohio), directing the attorney general to establish uniform standards for the exchange of controlled substance and prescription information for the purpose of preventing diversion, fraud and abuse of controlled substances and other prescription drugs; and,
• Sen. Tom CoburnTom CoburnCoburn: I haven't seen 'self-discipline' from Trump McCain: No third-party foes coming for Trump Tough choice for vulnerable GOP senators: Embrace or reject Trump MORE (R-Okla.), to require an independent assessment of the FDA's review of drug applications.
Harkin also announced that another amendment from Coburn would be withdrawn — a proposal to require the Health and Human Services secretary to ensure that performance awards are connected to employee evaluations.
Senate Majority Leader Harry ReidHarry ReidDems leery of Planned Parenthood cuts spark Senate scuffle Overnight Finance: Senate sends Puerto Rico bill to Obama | Treasury, lawmakers to meet on tax rules | Obama hits Trump on NAFTA | Fed approves most banks' capital plans Senate passes Puerto Rico debt relief bill MORE (D-Nev.) said Thursday morning that he hoped some of the remaining 11 amendments to the FDA bill could be handled quickly. With the four unanimous consent votes, seven roll-call votes remain before final passage. These votes are scheduled for 2 p.m., but Reid said he hoped they might start earlier.